Skip to content

H.R. 10369 · 119th Congress (2025–2027)

Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026

To amend title XVIII of the Social Security Act, and the Employee Retirement Income Security Act of 1974, to create certain requirements with respect to pharmacy benefit managers.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 10369’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Ryan Mackenzie (R-PA-7)
Cosponsors
4 cosponsors

4 original · 0 later

  1. Rep. Jake Auchincloss (D-MA-4)· Original · Sep 14, 2026
  2. Rep. Rick W. Allen (R-GA-12)· Original · Sep 14, 2026
  3. Rep. Carol D. Miller (R-WV-1)· Original · Sep 14, 2026
  4. Rep. Lucy McBath (D-GA-6)· Original · Sep 14, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEducation and WorkforceReferred Sep 14, 2026
  2. HouseEnergy and CommerceReferred Sep 14, 2026
  3. HouseWays and MeansReferred Sep 14, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026

    Display title, Short title · Introduced in House

  2. To amend title XVIII of the Social Security Act, and the Employee Retirement Income Security Act of 1974, to create certain requirements with respect to pharmacy benefit managers.

    Official title · Introduced in House